Article

Peripheral generation and function of CD4+CD25+ regulatory T cells.

Infection and Immunity Research Group, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NN, UK.
Current topics in microbiology and immunology (Impact Factor: 3.47). 02/2005; 293:115-31. DOI: 10.1007/3-540-27702-1_6
Source: PubMed

ABSTRACT The balance between immunity and tolerance is important to maintain immune homeostasis. Several mechanisms are in place to ensure that the immune response is controlled, such as T cell anergy, apoptosis and immune ignorance. A fourth mechanism of peripheral tolerance is the active suppression by regulatory or suppressor T cells. The existence of suppressor T cells was first described in the early 1970s, but these cells became discredited in the 1980s. The work of Shimon Sakaguchi and others, however, has brought these cells back into the limelight and nowadays research into regulatory/suppressor T cells is a very active field of immunology. Different types of regulatory T cells have been described, including CD4+CD25+ T cells that constitutively express CTLA-4, GITR and Foxp3, TGF-beta producing Th3 cells, IL-10 producing Tr1 cells, and CD8+CD28- T cells. This review will focus on the generation and function of CD4+CD25+ regulatory T cells. CD4+CD25+ regulatory cells were originally described as thymus-derived anergic/suppressive T cells. Recent papers, however, indicate that these cells might also be generated in the periphery. CD4+CD25+ regulatory T cells can be activated by self-antigens and non-self-antigens, and once activated can suppress T cells in an antigen nonspecific manner. Interestingly, the suppressive effects of these cells are not restricted to the adaptive immune system (T and B cells) but can also affect the activation and function of innate immune cells (monocytes, macrophages, dendritic cells). These features make the CD4+CD25+ regulatory T cell subset an interesting target for immunotherapy of chronic inflammatory or autoimmune diseases.

1 Follower
 · 
58 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: CD4(+)CD25(high)Foxp3(+) regulatory T cells (Tregs), as an active mechanism of immune suppression, have been targeted due to their tremendous therapeutic potentials to prevent autoimmune diseases, transplant rejection, and to inhibit progression of tumors and chronic viral diseases. In last twelve years, substantial molecular differences between homeostasis of Tregs and that of other subsets of T cells and some factors specific in regulation of Treg survival have been characterized. In this overview we focus on panoramic reviewing of 91 factors, pathways and drugs, both well-characterized and newly defined, regarding the survival and homeostasis of Tregs in the following sections: 2: Tregs, an essential mechanism of immune tolerance; 3: nTregs, aTregs and other regulatory T cells; 4: co-stimulation receptor signaling; 5: innate immunity and Toll-like receptor (TLR) signaling; 6: effects of cytokines and hormones; 7: transcription factors in regulation of Tregs; 8: Treg intracellular signaling and IL-4 cytokines exert their protective function on CD4+ T cells in the presence of soluble CD4 ligands, shows that they are able to reduce susceptibility to Bax-mediated apoptosis but not to CD95-dependent apoptotic pathways (289). A recent report from our laboratory showed that Tregs express higher levels of Bax than CD4+CD25- T cells (278). Our results further demonstrated for the first time that removal of Tregs via a Bax-dependent apoptosis pathway significantly enhances anti-self-tumor antigen immune responses (278), which points out that apoptosis pathway of Tregs is a new therapeutic target for treatment of immune related diseases.
    Frontiers in Bioscience 01/2008; 13(13). DOI:10.2741/2775 · 4.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although mechanisms leading to brain-specific inflammation and T cell activation have been widely investigated, regulatory mechanisms of local innate immune cells in the brain are only poorly understood. In this study, to our knowledge we show for the first time that MHC class II(+)CD40(dim)CD86(dim)IL-10(+) microglia are potent inducers of Ag-specific CD4(+)Foxp3(+) regulatory T cells (Tregs) in vitro. Microglia differentially regulated MHC class II expression, costimulatory molecules, and IL-10 depending on the amount of IFN-γ challenge and Ag dose, promoting either effector T cell or Treg induction. Microglia-induced Tregs were functionally active in vitro by inhibiting Ag-specific proliferation of effector T cells, and in vivo by attenuating experimental autoimmune encephalomyelitis disease course after adoptive transfer. These results indicate that MHC class II(+)CD40(dim)CD86(dim)IL-10(+) microglia have regulatory properties potentially influencing local immune responses in the CNS.
    The Journal of Immunology 10/2013; 191(11). DOI:10.4049/jimmunol.1203331 · 5.36 Impact Factor
  • Source

Leonie S Taams